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Background: Chronic obstructive pulmonary disease (COPD) is a major cause of acute hospital admissions. The
main object of our study was to evaluate the effects of telemedicine video-consultation (TVC) on the frequency of
hospital re-admissions due to COPD exacerbations. Our secondary aim was to assess the impact of TVC on the
length of re-admission stays within 6 and 12 months follow up after TVC. Patient satisfaction was also evaluated.
Methods: The study was a retrospective observational study of COPD patients who after hospital discharge or
during outpatient treatment for acute COPD exacerbations, were monitored for 2 weeks by TVC at home by a
specialist nurse at the hospital during a pilot project period. Retrospectively, we compared the frequencies
(chi-square test) and durations of hospital re-admissions (paired t-test) due to COPD exacerbations within 6 and 12
months follow up after TVC to comparable events 6 and 12 months prior to TVC.
Results: Among 99 patients followed for 6 months after TVC, 56 were followed for totally 12 months. The number
of patients re-admitted and the number of re-admissions due to COPD exacerbations were not reduced within 6 or
12 months post-TVC, as compared to 6 and 12 months pre-TVC.
The mean length of re-admission stays within 12 months post-TVC was markedly reduced as compared to pre-TVC.
Patients hospitalised the last 6 and 12 months pre-TVC, had significantly shorter re-admission stays, p = 0.033 and
p = 0.001, respectively. Patient satisfaction was high.
Conclusion: Despite the failure to demonstrate reduced frequency of re-admissions within 6 and 12 months
post-TVC, the re-admission length within 12 months post-TVC was markedly reduced as compared to pre-TVC. The
patient satisfaction was high. Future prospective, randomised, controlled trials must be performed before TVC can
be recommended in COPD management.
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Chronic obstructive pulmonary disease (COPD) is a ma-
jor cause of acute hospital admissions [1-3]. Approxi-
mately 15,000 acute hospital admissions per year in
Norway [4], 20% of all emergency admissions, are due to
acute COPD exacerbations. In Norway, 20,000 COPD
patients have severe disease with forced expiratory vol-
ume in the first second (FEV1) < 50% of expected value
[3]. As the severity of the disease increases, exacerba-
tions are more frequent, and the hospitalisation fre-
quency increases [5]. In the study by Eagen et al. [4],
13% of patients in Western Norway admitted with an
acute COPD exacerbation were re-admitted within the
first 30 days after discharge, in accordance with the find-
ings from a Danish study [6]. The rate of re-admission
within one year in the Danish study was 46% [6], while
British reports have suggested that 30% were re-admitted
within 90 days [7].
Several reports published during recent years have stu-
died if COPD care can be improved through nurse tele-
medicine consultation when monitoring COPD patients
at home and thus if it can prevent hospital admissions
[8-16]. However, few studies implement telemedicine
video-consultation (TVC) when monitoring COPD pa-
tients at home [12,16,17], using information technology
to monitor patients at home, while the clinician stays in
the hospital.
Recent experiences from a non-randomised study,
using TVC in Denmark when monitoring COPD patient
in their homes [17], have shown 14% reduction of early
re-admissions (within 28 days), probably related to early
onset of treatment of exacerbations, with rapid effect
and less drug use.
The Dalane District Medical Centre (DMC)/Egersund
Hospital, part of the Stavanger University Hospital, was
the first Norwegian hospital that initiated a pilot project
to adopt the same equipment for TVC with the pur-
pose of possibly reducing the frequency of hospital re-
admissions and improving quality of life for the COPD
patient.
The main aim of this study was to evaluate the effects
of TVC, between the respiratory nurse in the hospital
and the COPD patient at home, on the frequency of
hospital re-admissions within 6 and 12 months after dis-
charge from Stavanger University Hospital for COPD ex-
acerbation. Our secondary aim was to assess the impact
of TVC on the length of the recurrent hospital stays
within 6 and 12 months follow up after TVC. Moreover,
we wanted to assess patient satisfaction related to TVC.
Methods
Study design
The study is conducted as a retrospective uni-center ob-
servation study of a population of COPD patients whoafter discharge from hospital, or during outpatient treat-
ment for acute COPD exacerbation, was monitored for 2
weeks by TVC between the specialist respiratory nurse
at the hospital in Egersund, Stavanger University Hos-
pital, and the COPD patient at home during the pilot
project period from 16 April 2010 to 31 December 2011.
Two weeks’ intervention was based on the benefits ob-
served among the Danish patients who had the TVC
equipment at home for about one week followed by at
least one phone-call [17]. The main purpose was to
teach patients to increase empowerment, self-care and
correct medication in a more stabilised condition than
the acute phase of hospitalisation. In order to study a
possible change in amount of hospital admissions due to
acute COPD exacerbations we have compared the fre-
quencies and durations of such events before and after
TVC in comparable time periods. Admissions due to
other causes than acute COPD exacerbations have not
been included in this study. The index hospitalisation
was not included.
Study population
All COPD patients living in the southern part of
Rogaland county in Western Norway, with a habitual
value of FEV1< 50%, who had been monitored at home
by TVC following discharge after emergency hospitalisa-
tion for COPD exacerbation at Stavanger University Hos-
pital or DMC in Egersund, or who had tele-monitoring at
home under outpatient treatment for acute COPD deteri-
oration during the pilot project period, were included in
the follow up registration study. COPD exacerbation was
defined as increased need for COPD medication due to
worsened dyspnoea, cough or increased amount of or pu-
rulent sputum (not due to any other underlying lung or
heart disease), with or without a pneumonia.
Written informed consent was obtained from each
participant, and inclusion criteria comprise willingness
to participate, age > 40 years, no active malignant or any
other disease with prognostic life expectancy shorter
than 12 months, not previously included in the study,
residence outside in-service-housing with care or nurs-
ing homes, and ability to communicate. Thus, also pa-
tients with hearing impairment, aphasia or dementia
were excluded from the TVC service and the study.
In-hospital treatment was in accordance with hospital
policy and Norwegian National guidelines for preven-
tion, diagnosis and monitoring of individuals with COPD
and included bronchodilators inhaled by nebuliser, sys-
temic steroids, antibiotics, oxygen supply, chest phy-
siotherapy and when needed non-invasive ventilatory
support (NIV) according to BTS guidelines [18].
Power calculations have not been performed for the
purpose of this pilot study, because of too many un-
known factors. The results of this study will form the
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domised study.
Telemedicine video-consultation (TVC), patient monitoring
and follow up
The telemedicine equipment consisted of a computer
with a web camera with a microphone, through which
the patient at home and the specially trained nurse in
hospital were able to communicate, and also comprised
requisites to measure the patient’s oxygen saturation and
heart rate, and to perform a spirometry. The results
were transferred to the hospital by a secure internet line.
The computer had two buttons; one to contact the nurse
according to daily appointments for TVC on week-days
during day-time, and one alarm button to be pressed in
case of acute need for consultation whenever necessary,
24 hours a day the whole week.
During the TVC the nurse made clinical observations
according to a checklist (Table 1), measured oxygen sat-
uration, and advised the patient how to cope with COPD
related symptoms, use of medication and how to main-








• Level of functioning
• Physical activity
• Inhalation technique
• Number of short-acting inhalations last day
• Use of on-going inhalation medication
• Use of antibiotics





• Use of accessory breathing muscles
• Prolonged expiration
• Heart rate (beats/minute)
• Use of oxygen supply
• Oxygen saturation (%)
• Other medication
• Marks [consultations with doctor, home-nurse, physiotherapist or ergo-
therapist, emergency calls]could confer the patient with the doctor in the hospital,
a physiotherapist or an occupational therapist, or advise
the patient to consult a general practitioner or a home
care nurse.
A detailed patient history comprising demographic da-
ta, social status, smoking habits, body mass index (BMI),
use of medication, comorbidity and the habitual lung
function were registered. Dates of admittance and dis-
charge were noted. Retrospectively, medical records were
scrutinised for re-admissions due to COPD exacerbations
at 6 and 12 months follow up. Frequency of and date of
re-admissions, length of hospital stay, and clinical data
were recorded. Also frequency of admission due to COPD
exacerbation and length of hospital stay(s) during the last
6 and 12 months prior to the TVC were recorded. Finally,
all patients were encouraged to complete a questionnaire
concerning patient satisfaction and impact on patient’s
quality of life. All answers were registered anonymously.
Our primary endpoint was number of patients re-
admitted and frequency of hospital re-admissions due to
acute COPD exacerbations during 6 and 12 months fol-
low up after TVC.
Our secondary endpoints included length of recurrent
hospital stay(s). As we have no control group, our data
are compared to similar data from the 6 and 12 months
preceding TVC. Finally, we wanted to assess patient sat-
isfaction related to TVC. All patients were encouraged
to complete a questionnaire (Table 2) concerning patient
satisfaction and impact on patient’s quality of life. The
questionnaire, together with an explanation, was sent to
the patient when finalizing the TVC. All answers were
registered anonymously.
The study was approved by the Regional Board of Re-
search Ethics and conducted in accordance with the
Declaration of Helsinki [19,20].
Statistical methods
Continuously distributed variables of baseline characte-
ristics were given as mean ± SEM, while variables with
more skewed distributions were given as median and
upper and lower quartiles.
The Shapiro-Wilk test for normality was performed to
study the distribution of parameters. A chi-square test
was applied to compare the frequency of re-admissions
during 6 and 12 months following TVC to the frequency
of hospital admissions during the last 6 or 12 months
prior to TVC. The total number of days in hospital du-
ring the 6 and 12 months prior to TVC was compared
to number of days in hospital during 6 and 12 months
following TVC by a paired t-test. Differences in baseline
characteristics between patients who were re-admitted
and those who were not, were analysed by a Two-
sample Student’s T-test, or in case of non-normality,
by the Mann–Whitney Rank Sum test. A multiple logistic
Table 2 Questions to patients regarding patient
satisfaction and user friendliness of TVC equipment
1. How do you usually feel at discharge from hospital after COPD
exacerbation?
Very safe – Safe – Unsafe – Very unsafe
2. At discharge the TVC service made me feel
Very safe – Safe – Unsafe – Very unsafe
3. How do you consider the significance of the TVC for your ability to




4. Retrospectively, if you could choose, would you prefer a telephone
consultation rather than tele-video-consultation?
- I would prefer talking to the nurse by phone
- I would prefer the tele-video-consultation
5. Which of the following statement fits you best concerning your
experience of user-friendliness of the TVC equipment?
- It was easy to operate the TVC equipment
- It was a bit difficult to operate the TVC equipment
- I could not manage to operate the TVC equipment
6. Who was operating the tele-video conferencing system at home?
- You, every time
- A friend or a relative operated the tele-video-conferencing system
every time
- Different persons operated the tele-video-conferencing system
every time
- The tele-video-conferencing system was not in use
Table 3 Baseline demographic and clinical characteristics
(n = 99)
Age [ys; mean (SEM)] 70.6 (0.95)
Men [n (%)] 45 (45.9)
Living alone [n (%)] 47 (47.5)
Having Home nursing [n (%)] 46 (46.5)
Current smoker [n (%)] 27 (27.3)
Ex-smoker [n (%)] 69 (69.7)
BMI [kg/m2; mean (SEM)] 23.4 (0.63)
Cardiovascular disease [n (%)] 51 (57.6)
Depression [n (%)] 40 (40.4)
FEV1 [liter; mean (SEM)] 0.99 (0.07)
FEV1% [%; mean (SEM)] 36.4 (1.61)
LTOT* at home [n (%)] 16 (16.2)
NIV** at home [n (%)] 15 (15.2)
LTOT*, Long Term Oxygen Treatment; NIV**, Non-Invasive Ventilatory Support.
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dent variable and several baseline characteristics as poten-
tial independent predictors of re-admission was applied.
A statistically significant level of p < 0.05 was applied
for all tests. All statistical analyses were performed using
the statistical package of SigmaPlot Version 12.
Results
Baseline data
Ninety-nine patients were followed for 6 months after
TVC, out of whom 56 could be followed for a total of 12
months before the closure of the study on 31 December
2012. Three patients died in an outpatient setting with-
out being re-admitted, and only 3 patients died after 6
months follow up.
The baseline demographic and clinical characteristics
of all patients with 6 months follow up are presented in
Table 3. The patients were residents of 13 different mu-
nicipalities in Rogaland; 44% lived in the two most
densely populated municipalities. Prior to TVC, 78 pa-
tients (78.8%) were hospitalised at Stavanger University
Hospital, while the remaining had outpatient treatment
for the COPD exacerbation prior to TVC. During indexadmission, all patients inhaled ipratropium and salbuta-
mol by nebuliser, and all except 3 patients were treated
with systemic corticosteroids, while 94.9% of patients
received antibiotics. Respiratory failure with need for
oxygen supply during hospital stay was reported among
64.6% of patients, and 11.5% of patients, presenting with
pH < 7.35 and hypercapnia, were treated with non-in-
vasive ventilatory support according to BTS guidelines
[18]. The high rate of 85.7% of patients inhaling com-
bination products of long acting beta-2-agonist and cor-
ticosteroid as part of the on-going regular medication
reflects the severity and the symptom burden of COPD
in this population. Nearly all patients were treated with
either ipratropium or tiotropium. Twenty-seven patients
(27.3%) were classified in COPD Gold stadium IV, with
FEV1 ≤ 30% of expected.
The patients were monitored by TVC for 14.3 (0.63)
days [mean (SEM)], consulting 3 (2–4) nurses [median
(interquartile range)] through 10 (9–11) planned and ag-
reed consultations [median (interquartile range)]. There
were no emergency calls during this pilot phase.
During TVC 12 patients started systemic steroid ther-
apy and 14 patients started antibiotics, out of whom 11
patients started combination therapy of systemic steroids
and antibiotics. The oxygen saturation remained un-
changed from TVC start (9.3.9% ± 0.29%) to end of TVC
(93.8 ± 0.46), p = 0.26.
Follow up data
Frequency of re-admission due to acute COPD
exacerbations
During 6 and 12 months follow up after TVC at home,
we could not observe a statistically significant reduction
in number of patients re-admitted due to COPD exacer-
bations, as compared to the last 6 and 12 months prior
Table 5 Frequency distribution of admissions due to
COPD exacerbations among patients followed for 12
months
Number of hospital stays 0 1 ≥ 2
Re-admission (n) 15 14 27
Admission prior to TVC (n) 13 16 27
Number of patients with 0, 1 or ≥ 2 re-admissions within 12 months follow up
after TVC as compared to during the last 12 months prior to TVC; n, number
of patients.
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tients (50.5%) were re-admitted due to COPD exacer-
bations, and 50 patients (50.5%) had been admitted the
preceding 6 months, p = 0.887. However, following each
of the 50 patients hospitalised during the 6 months prior
to TVC, 19 were not re-admitted within 6 months fol-
lowing TVC. Re-admissions due to other causes than
acute COPD exacerbations were not included in this
study.
Within 12 months follow up after TVC, 41 patients
(73.2%) were re-admitted due to COPD-exacerbations,
while 43 patients (76.8%) had been admitted the preced-
ing 12 months, p = 0.827. Following each of the 43 pa-
tients hospitalised during the 12 months prior to TVC,
12 were not re-admitted within 12 months following
TVC.
The frequency distribution of re-admissions due to
COPD exacerbations as compared to admissions 6 and
12 months preceding TVC is depicted in Tables 4 and 5.
Patients who were re-admitted, were slightly older
than those who were not, with a mean age of 72.4 (1.29)
vs 68.5 (1.36) years, respectively. The re-admitted ones
and those who were not re-admitted did not differ regard-
ing to sex, baseline FEV1, cardiovascular comorbidity,
blood gas values or low BMI (< 20). In the multiple logis-
tic regression model age [odds ratio (OR) 1.11 (95% CI
1.01 – 1.22, p = 0.043), BMI [OR 1.13 (95% CI 1.01 – 1.27,
p = 0.032] and male sex [OR 5.12 (95% CI 1.18 – 22.22,
p = 0.029] were identified as predictors of re-admission,
while pulmonary function parameters, a history of pre-
vious admission, current smoking or status of living alone
were not associated with re-admission.Length of hospital stays due to acute COPD exacerbations
before and after TVC
The length of re-admission hospital stays (days; mean ±
SEM) due to COPD exacerbations within 12 months fol-
lowing TVC was significantly reduced as compared to
12 months prior to TVC, as depicted in Table 6. A simi-
lar tendency was noted for patients followed for 6 months,
but did not reach statistical significance (Table 6). Asses-
sing only patients hospitalised the last 6 and 12 months
prior to TVC, we noted significantly shorter hospital staysTable 4 Frequency distribution of admissions due to
COPD exacerbations among patients followed for 6
months
Number of hospital stays 0 1 ≥ 2
Re-admission (n) 49 14 36
Admission prior to TVC (n) 49 24 26
Number of patients with 0, 1 or ≥ 2 re-admissions within 6 months follow up
after TVC as compared to during the last 6 months prior to TVC; n, number
of patients.when re-admitted within 6 and 12 months following
TVC, p = 0.033 and p = 0.001, respectively (Table 7).
Patient satisfaction
Among survivors, the response rate to the survey was
90%. While 52.4% of patients responded retrospectively
that they generally felt safe or very safe when discharged
from hospital without TVC, 90.5% of patients retros-
pectively reported safety when discharged to TVC at
home, p < 0.001. Nearly 48% of patients found that TVC
had great importance for their further management of
their COPD related problems. Ninety-six percent of pa-
tients found the telemedicine equipment easy to operate,
and 95.2% of patients reported that they handled the
tele-video conferencing system on their own.
Moreover, 78.7% of patients preferred TVC above only
phone calls.
There were few technical problems. Cancellation of
the TVC occurred some times due to internal IT issues.
Reproducible spirometry results were difficult to obtain
in many patients, thus spirometry results are not given
in our report.
Discussion
Our study is the first to demonstrate a marked reduction
in the length of hospital re-admissions in patients with
COPD during a 12 month period following intervention
with TVC, as compared to the last 12 months prior to
TVC. Moreover, patients who had been admitted the last
6 or 12 months prior to TVC, had shorter hospital stays
when re-admitted following TVC, meaning important
savings in health costs for the community and improved
quality of life for the patient. Only confirmation of these
findings in a prospective, randomised, controlled trial
could position TVC as an important new contribution
to standard management of these patients.
In this retrospective pilot study we could, however, not
demonstrate a reduction in the rate of hospital re-
admission due to COPD exacerbations during 6 and 12
months follow up after TVC, as compared to prior to
TVC. Thus, our observations are not in agreement with
the Danish study using the same equipment [17], demon-
strating 10% reduction in re-admissions due to COPD ex-
acerbations in the TVC group as compared to a control
Table 6 Mean length of hospital stays before and after TVC during comparable time periods (all patients)








Days 11.6 6.3* 7.1 4.5**
[mean (SEM)] (2.16) (0.80) (1,92) (0.64)
Mean length of hospital stays (days) before and after TVC during comparable time periods in all patients followed for 6 months (n = 99) and for 12 months
(n = 56) after TVC.
*p = 0.023, **p = 0.200 (Paired t-test).
Saleh et al. Multidisciplinary Respiratory Medicine 2014, 9:6 Page 6 of 8
http://www.mrmjournal.com/content/9/1/6group. However, the observational period after TVC in
that study was 28 days.
A previous history of COPD exacerbation has been
suggested to be the most reliable predictor of COPD ex-
acerbations [5,21]. Additionally, data from the Evaluation
of COPD Longitudinally to Identify Predictive Surrogate
Endpoints (ECLIPSE) [5] showed that 33% with COPD
stage 3 and 47% with stage 4 defined according to the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) [22] had ≥ 2 exacerbations in the first year of
follow up. Our patients are characterised by COPD stage
3–4, with a mean FEV1 of 36.3%, and 67.9% had been
admitted the last year. In accordance with previous ob-
servations [17,23], higher age and male gender was asso-
ciated with an increased risk of re-admittance in our
study.
Our main finding was the reduction in days per ad-
mission when in need of hospitalisation. Several factors
could have influenced this observation. In addition to
the introduction of TVC, a change in treatment or hos-
pitalisation policies might have influenced this. There
are, however, no new treatments introduced in the study
period at the hospital. In addition, on-going regular me-
dication was similar at inclusion and at discharge from
index hospital stay (prior to TVC), and no change in
conventional medical therapy could explain this diffe-
rence. Regarding hospitalisation policies, “The new Co-
ordination Reform”, guaranteeing immediate help from
the municipality health care system when discharged
from hospital, such as a place in a nursing home, came
into force in Norway the 1st of January 2012. This re-
form does not seem to explain the shorter length of hos-
pital stays in this study, as the patients receiving TVC in
this study, were not candidates for nursing homes. Be-
sides, more than 60% of the re-admissions occurredTable 7 Mean length of hospital stays before and after TVC in





[mean (SEM)] (2.59) (0.85)
(n = 43
Mean length of hospital stays (days) when admitted within the last 6 months (n = 5
(days) within 6 and 12 months following TVC.
*p = 0.001, ** p = 0.033 (Paired t-test).among the 49 first included patients whose 12 months
follow up were completed before “The Coordination
Reform” came into force.
We therefore believe that the observed changes in
length of hospital stays were related to the introduction
of the TVC. Many advances related to the TVC could
contribute to the benefit of reduced length of hospital
stays when re-admitted. During the TVC period, the spe-
cially trained nurse not only daily monitored and advised
each patient according to personal needs to improve the
actual health condition. Also, great effort was invested
in advising and teaching each patient to increase the
empowerment and competence for good self-care, con-
cerning correct medication use, inhalation technique, ap-
propriate physical activity, pulmonary drainage, dealing
with stress and anxiety to prevent and to cope with future
exacerbations. However, our study has not been designed
to directly evaluate the influence of TVC on each of those
factors.
An interdisciplinary team was available for consult-
ation when needed, including among others a physio-
therapist and an occupational therapist, who could for
example easily facilitate home conditions, and thereby
also enable a faster and smoother future hospital dis-
charge. The discharge policy of the hospital, defined in
the hospital’s quality criteria, has not changed before
and after the TVC during the study period, ensuring a
stabilised patient without need for fast-acting bronchodi-
lators more frequently than every 4 hour, whose ability
to eat and sleep is not limited by breathlessness, ensur-
ing the patient appropriate home conditions, and that
the patient, relatives and eventually nursing staff can ad-
minister the prescribed treatment, that an ambulatory
patient can walk at least 20 meters, and the need of inter-









) (n = 50)
0) and 12 months (n = 43) prior to TVC as compared to length of re-admissions
Saleh et al. Multidisciplinary Respiratory Medicine 2014, 9:6 Page 7 of 8
http://www.mrmjournal.com/content/9/1/6in order to guarantee that the patient will manage at
home. The marked reduction after TVC of the relatively
long hospital stay might therefore be related to a facili-
tated discharge process and safeguarding of home condi-
tions offered by TVC. However, home nursing was equally
frequent among those who were re-admitted and those
who were not. Thus, home-nursing does not seem to pre-
vent re-admissions. There was no change in the hospital’s
discharge policy during the study period.
The self-perceived patient satisfaction and the in-
creased coping skills following TVC are also of major
importance for the feeling of safety at home, which was
reported high in the enquiry.
The marked reduction in use of hospital resources
after introduction of TVC in this pilot study gives promise
for a better management of COPD patients. This could in-
duce both a better life and feeling of safety for the patients
and reduce the costs for the society. Further, the results
presented in this report, are based on the experience from
the early start of TVC at our site with a strict use of
the equipment for 2 weeks. The accumulated experience
through the development of the program indicates even
better effects by applying an individualised approach with
some patients with shorter follow up and longer in others,
based on their individual condition and needs. It is
therefore possible that a future, more flexible, individually
adapted duration of TVC monitoring of patients might
even contribute to increase periods free of re-admissions,
rather than the strict, pre-determined period of 14 days of
TVC monitoring, used in our study, irrespective of patient
condition and needs.
For majority of patients the need of re-admission has
been decided by occurrence of an infective exacerbation,
as nearly 70% of patients re-admitted, required anti-
biotic therapy during the first re-admission. Thus, these
re-admissions are hard to avoid, but the length of
re-admission hospital stays were shortened, as already
discussed.
The major limitation of this study is, of course, the
retrospective design and the lack of a control group.
This pilot study is, however, inspiring to perform a ran-
domised, controlled trial evaluating the effect of TVC on
re-admissions and length of hospital stays due to COPD
exacerbations. Moreover, DMC was the first centre in
Norway applying TVC, being a pioneer, establishing a
new therapeutic approach in our region, and the concept
has probably improved by time, gaining more experi-
ence. Including also the first patients participating might
have influenced the results of our investigation. On the
other hand, the TVC system has been user friendly both
for the patients and the nurses, experiencing few tech-
nical problems, the nurses have been well skilled and
trained, and both the patient confidence in the TVC ser-
vice and the patient satisfaction were high.Cost-benefit analysis has never been an aim of this
pilot study, and future research is needed to confirm the
cost effectiveness of TVC for COPD patients.
Conclusions
In conclusion, despite the failure to demonstrate a re-
duced frequency of re-admittance within 6 and 12 months
following TVC, as compared to pre-TVC in this pilot
study, the length of the re-admission stays within 12
months following TVC was considerably reduced as com-
pared to pre-TVC. Patients who had been admitted prior
to TVC, had shorter hospital stays when re-admitted
post-TVC. The patient satisfaction was high. Future ran-
domised, controlled trials must be performed to confirm
the results of this pilot study and to verify that the TVC
does not offer a lower solution to hospital safety.
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